Ramasamy Jagadeeswaran to Anemia, Sickle Cell
This is a "connection" page, showing publications Ramasamy Jagadeeswaran has written about Anemia, Sickle Cell.
Connection Strength
1.316
-
Evolving treatment paradigms in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):440-446.
Score: 0.491
-
Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. Exp Hematol. 2017 06; 50:46-52.
Score: 0.465
-
Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons. Exp Hematol. 2018 11; 67:60-64.e2.
Score: 0.129
-
Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data. Am J Physiol Regul Integr Comp Physiol. 2018 10 01; 315(4):R840-R847.
Score: 0.128
-
RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases ?-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model. Exp Hematol. 2015 Jul; 43(7):546-53.e1-3.
Score: 0.102